Lack of adverse clopidogrel-atorvastatin clinical interaction -: Reply

被引：0
|
作者：
Wienbergen, H
Senges, J
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 05期
关键词：
D O I：
10.1016/j.amjcard.2003.08.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：669 / 670
页数：2
相关论文
共 50 条
  • [31] Clinical evidence of interaction between clopidogrel and proton pump inhibitors
    Lin, Shoa-Lin
    Chang, Hui-Min
    Liu, Chun-Peng
    Chou, Li-Ping
    Chan, Jaw-Wen
    WORLD JOURNAL OF CARDIOLOGY, 2011, 3 (05): : 153 - 164
  • [32] The Clinical Relevance of the Clopidogrel-Proton Pump Inhibitor Interaction
    Mohammad, Atif
    Brilakis, Emmanouil S.
    Weideman, Rick A.
    Little, Bertis B.
    Banerjee, Subhash
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (04) : 547 - 552
  • [33] Clinical relevance of clopidogrel-proton pump inhibitors interaction
    Stella D Bouziana
    Konstantinos Tziomalos
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2015, (02) : 17 - 21
  • [34] Conflicting Evidence Surrounding the Clopidogrel and Proton Pump Inhibitor Drug Interaction Reply
    Stockl, Karen M.
    Harada, Ann S. M.
    Solow, Brian K.
    Addiego, Joseph E.
    Ramsey, Scott
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (16) : 1508 - 1508
  • [35] Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome
    Mukherjee, D
    Kline-Rogers, E
    Fang, J
    Munir, K
    Eagle, KA
    HEART, 2005, 91 (01) : 23 - 26
  • [36] Atorvastatin–Green Tea Interaction: Possible Mechanisms are Complicated, But Clinical Relevance is Not?
    Shingen Misaka
    Kenju Shimomura
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 423 - 425
  • [37] Clinical Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors
    Bykov, Katsiaryna
    Schneeweiss, Sebastian
    Donneyong, Macarius M.
    Dong, Yaa-Hui
    Choudhry, Niteesh K.
    Gagne, Joshua J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 257 - 258
  • [38] ADVERSE BIOCHEMICAL AND CLINICAL CONSEQUENCES OF FUROSEMIDE ADMINISTRATION - REPLY
    SELLERS, EM
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1978, 119 (10) : 1169 - 1170
  • [39] Adverse event development in clinical oncology trials reply
    Thanarajasingam, Gita
    Sloan, Jeff A.
    Grothey, Axel
    LANCET ONCOLOGY, 2016, 17 (07): : E264 - E265
  • [40] Clopidogrel - proton pump inhibitors drug interaction: implications to clinical practice
    Fontes-Carvalho, Ricardo
    Albuquerque, Anibal
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2010, 29 (10) : 1555 - 1567
12345